Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 7, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (2)

RECRUITING

Medical Surgical Associates Center, St John's

RECRUITING

Center for Investigation in Tissue Engineering and Cellular Therapy, Buenos Aires

All Listed Sponsors

lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER